<?xml version="1.0" encoding="UTF-8"?>
<p id="Par17">
 <italic>V</italic>. 
 <italic>cholerae</italic> specific phages encoding their own functional CRISPR-Cas system to neutralize a bacterial defense mechanism against phages has been discovered recently
 <sup>
  <xref ref-type="bibr" rid="CR6">6</xref>
 </sup>, but the origin of the CRISPR-Cas system carried by the phages remains unknown. Mechanisms such as genome rearrangements, and genomic exchange with other viral or microbial genomes to acquire new traits allow phages to evolve rapidly, facilitated by their genomic plasticity and fast multiplication rates. However, the CRISPR-Cas systems carried by 
 <italic>V</italic>. 
 <italic>cholerae</italic> O1 classical biotype strains or 
 <italic>V</italic>. 
 <italic>cholerae</italic> non-O1 non-O139 strains, were found to differ widely from that carried by the phages (Fig.Â 
 <xref rid="Fig6" ref-type="fig">6</xref>). Moreover, the CRISPR-Cas carried by the 
 <italic>V</italic>. 
 <italic>cholerae</italic> non-O1 non-O139 strains were found to be located in a chromosomal island which also carry genes for the Type VI secretion system, as described previously
 <sup>
  <xref ref-type="bibr" rid="CR22">22</xref>,
  <xref ref-type="bibr" rid="CR23">23</xref>
 </sup>. The marked difference at the nucleotide level and absence of features associated with horizontal transfer, suggest that its highly unlikely that the phage encoded CRISPR-Cas was derived from that found in the 
 <italic>V</italic>. 
 <italic>cholerae</italic> non-O1 non-O139 strains. Thus the origin of the CRISPR-Cas locus in cholera phages remains to be identified.
</p>
